Genpact Limited (G) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 23/100
- 10Y CAGR
- 7.5%
- Median YoY
- 6.7%
- YoY volatility
- σ 4.8pp· very smooth
- Quarters ≥ 20%
- 1 of 40
- Negative quarters
- 0
- Valuation vs own 10Y history
- P/S 1.2x · 10Y median 2.0x · 3rd percentile · as of Aug 19, 2026
How this score is computed
- Quarters at or above 20%: 1 of 40 → 1 of 40 pts
- Steadiness (typical swing 4.8pp) → 21.6 of 25 pts
- Pace (median 6.7% YoY) → 0 of 20 pts
- Latest quarter (7.1% YoY) → 0 of 15 pts
- Score: 23 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 7.5% | 6.7% | 4.8pp | 1 of 40 | 0 |
| EPSEPS | 11.1% | 12.1% | 40.7pp | 10 of 40 | 10 |
| Op cash flowOperating cash flow | 9.5% | 3.4% | 36.1pp | 12 of 31 | 12 |
| EBITDAEBITDA | 7.4% | 6.8% | 13.6pp | 8 of 40 | 10 |
| FCFFree cash flow | 10.7% | 1.3% | 44.3pp | 11 of 31 | 15 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: G on the compounders surface · All compounders, ranked